Welcome to Molecular Psychiatry
Molecular Psychiatry publishes papers elucidating the biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels.
ALSO FROM NATURE PUBLISHING GROUP: Translational Psychiatry
Editor-in-Chief: Julio Licinio, MD; Impact Factor 5.538*
Translational Psychiatry, a sister journal to Molecular Psychiatry, is an online-only, open access publication that provides high quality research, a respected editorial team, rapid publication and high visibility. Visit http://www.nature.com/tp.
Check out Molecular Psychiatry's recently published paper on stress-induced depression, co-authored by Nobel Laureate Paul Greengard!
Volume 22, No 1
January 2017
ISSN: 1359-4184
EISSN: 1476-5578
2015 Impact Factor 13.314*
4/140 Psychiatry
7/256 Neurosciences
7/289 Biochemistry & Molecular Biology
Editor:
Julio Licinio, MD
*2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016)
FEATURED ARTICLES
Expert Review
The birth, death and resurrection of avoidance: a reconceptualization of a troubled paradigm OpenExpert Review
Predictive analytics in mental health: applications, guidelines, challenges and perspectivesOriginal Article
Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trialOriginal Article
Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorderNEWS
Check out Molecular Psychiatry's recently published paper on stress-induced depression, co-authored by Nobel Laureate Paul Greengard!
Molecular Psychiatry was mentioned: A study published in Molecular Psychiatry provides evidence that children with lower socioeconomic status are more prone to mental illness. This study could with the development of strategies and personalized treatment for mental illness. Read the article or the news story!An Immediate Communication in Molecular Psychiatry reports a molecular mechanism whereby NMDA receptor antagonists such as ketamine can increase mTOR signaling to elicit antidepressant actions. Drugs selectively targeting components of this pathway may offer novel approaches to the treatments of depression. Read the report now.
Molecular Psychiatry is now a member of the Neuroscience Peer Review Consortium (NPRC). The purpose of the NPRC is to decrease the time and effort involved in the peer review process, and reduce the burden placed on reviewers. NPRC member journals agree to transfer manuscript reviews upon the author's request. A flowchart of the transfer process and a list of member journals can be found on the NPRC website.
Visit Nature Publishing Group's open access funding page for information about research funders and institutions that provide funding for open access. NPG also offers an APC support service to make it easier for NPG authors to discover and apply for open access funding. For advice on what funding is available to you and help in approaching funders and institutions, please contact us at openaccess@nature.com.
Want to order a poster of a Molecular Psychiatry journal cover? If so, follow this link to the order form.
TOP TEN MOST VIEWED PAPERS
The Top Ten charts the articles that have been downloaded most often over the previous 30 days, in HTML and PDF format, from the Molecular Psychiatry website. The chart does not rank the quality, scientific significance or citation impact of the content. However, it may bring articles to your attention that you might not have otherwise noticed. We hope you enjoy them.
January 2017
-
Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial
R E Frye, J Slattery, L Delhey, B Furgerson, T Strickland, M Tippett, A Sailey, R Wynne, S Rose, S Melnyk, S Jill James, J M Sequeira & E V Quadros
doi:10.1038/mp.2016.168
-
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
A Lacour, A Espinosa, E Louwersheimer, S Heilmann, I Hernández, S Wolfsgruber, V Fernández, H Wagner, M Rosende-Roca, A Mauleón, S Moreno-Grau, L Vargas, Y A L Pijnenburg, T Koene, O Rodríguez-Gómez, G Ortega, S Ruiz, H Holstege, O Sotolongo-Grau, J Kornhuber, O Peters, L Frölich, M Hüll, E Rüther, J Wiltfang, M Scherer, S Riedel-Heller, M Alegret, M M Nöthen, P Scheltens, M Wagner, L Tárraga, F Jessen, M Boada, W Maier, W M van der Flier, T Becker, A Ramirez & A Ruiz
doi:10.1038/mp.2016.18
-
Research and Reviews
Latest research highlights and reviews from the Springer Nature family of journals
-
Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation
- this content is FREE
Source: Gene -
Materials and technologies for soft implantable neuroprostheses
Source: Nature Reviews Materials -
A high-throughput-compatible assay to measure the degradation of endogenous Huntingtin proteins
- this content is FREE
Source: Acta Pharmacologica Sinica
-
Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation